Novel method of doxorubicin–SPION reversible association for magnetic drug targeting
- 3 November 2008
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 363 (1-2), 170-176
- https://doi.org/10.1016/j.ijpharm.2008.07.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cellsBiomaterials, 2008
- Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitroBiomaterials, 2006
- Recent advances in iron oxide nanocrystal technology for medical imaging☆Advanced Drug Delivery Reviews, 2006
- Protectors against doxorubicin-induced cardiotoxicity: FlavonoidsCell Biology and Toxicology, 2006
- Iron Oxide Nanoparticles for Sustained Delivery of Anticancer AgentsMolecular Pharmaceutics, 2005
- Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopyThe Analyst, 2005
- Functionalisation of magnetic nanoparticles for applications in biomedicineJournal of Physics D: Applied Physics, 2003
- How Fe3+ binds anthracycline antitumour compounds: The myth and the reality of a chemical sphinxJournal of Inorganic Biochemistry, 1999
- Extracellular pH distribution in human tumoursInternational Journal of Hyperthermia, 1995
- Self-reduction of the iron(III)-doxorubicin complexFree Radical Biology & Medicine, 1989